Jump to content
RemedySpot.com
Sign in to follow this  
Guest guest

NACO’s action on the side effects of Emcure’ Pharma's ARVs

Rate this topic

Recommended Posts

Guest guest

Dear forum,

It is really a great concern for those who are having some sense of

humanity.

Recently, I had the privilege to see the glimpse of SUJATA RAO in the

parliamentary FORUM in New Delhi.

I requested her to take some action on - Emcure's ARV medicine

which is causing problems to most of us- having severe side effects

which is leading untimely death of many.

But, her response was " If you want to take it - take it otherwise

you may buy medicine from outside "

I responded to her " Madam, You people are taking pledge to

provide quality in services " Emcure is providing Efevirenz for

Rs 30 and same medicine is being provided by others for Rs 80 to

90.

My understanding is that the money spend on this medicine is from a

loan given by the WORLD BANK and it will be paid by all the

citizens, including us and we are paying tax for that.

By the way, we have decided to have the Efficacy Test of this

medicine and in Rajasthan we are going to file PIL for it .

And then we have planning to claim to NACO for compensation for

those who have lost their life untimely.

We are waiting to get the efficacy test which is not from NARI but

from others .

Wishing all our best wishes to NACO

Brijesh Dubey

President [rnpplus]

e-mail: <rnpplus@...>

Share this post


Link to post
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
Sign in to follow this  

×
×
  • Create New...